12 Typical Cases Lead to Fines Surpassing 2.4 Billion Yuan; Antitrust Efforts Spur Over 90% Price Cuts for Certain Pharmaceuticals
2025-12-17 / Read about 0 minute
Author:小编   

The State Administration for Market Regulation convened a press conference to unveil the accomplishments of a dedicated antitrust enforcement initiative within the people's livelihood domain. This three-year drive, primarily targeting the pharmaceutical industry, delivered striking outcomes. A total of 12 significant typical cases were probed, resulting in fines and confiscations amounting to over 2.4 billion yuan. This initiative has catalyzed price reductions exceeding 90% for certain pharmaceuticals, significantly easing the financial strain of medication expenses on patients and curbing national healthcare insurance outlays.